tiprankstipranks
Castle Biosciences price target lowered to $40 from $44 at Scotiabank
PremiumThe FlyCastle Biosciences price target lowered to $40 from $44 at Scotiabank
1M ago
Castle Biosciences announces new data on DecisionDx-UM
Premium
The Fly
Castle Biosciences announces new data on DecisionDx-UM
1M ago
Castle supporting series of initiatives to raise awareness of skin cancer
Premium
The Fly
Castle supporting series of initiatives to raise awareness of skin cancer
1M ago
Castle Biosciences Reports Strong Q1 2025 Growth
PremiumCompany AnnouncementsCastle Biosciences Reports Strong Q1 2025 Growth
2M ago
Castle Biosciences to acquire Capsulomics, terms undisclosed
Premium
The Fly
Castle Biosciences to acquire Capsulomics, terms undisclosed
2M ago
Castle Biosciences reports Q1 adjusted EPS (20c), consensus (7c)
Premium
The Fly
Castle Biosciences reports Q1 adjusted EPS (20c), consensus (7c)
2M ago
Castle supports educational programs, initiatives for esophageal cancer
PremiumThe FlyCastle supports educational programs, initiatives for esophageal cancer
2M ago
Castle Biosciences announces publication of papers on DecisionDx-Melanoma test
Premium
The Fly
Castle Biosciences announces publication of papers on DecisionDx-Melanoma test
3M ago
Castle Biosciences price target lowered to $30 from $37 at Guggenheim
Premium
The Fly
Castle Biosciences price target lowered to $30 from $37 at Guggenheim
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100